A Boshier

Summary

Affiliation: Drug Safety Research Unit
Country: UK

Publications

  1. ncbi request reprint Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England
    Deborah Layton
    Drug Safety Research Unit, Southampton, Hants, UK
    Drug Saf 29:897-909. 2006
  2. ncbi request reprint Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000
    Andrew Boshier
    Drug Safety Research Unit, Southampton, UK
    Eur J Clin Pharmacol 59:767-73. 2003
  3. ncbi request reprint Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999
    A Boshier
    Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton SO31 1AA, UK
    BJU Int 93:796-801. 2004
  4. ncbi request reprint The negative effect of red tape on research
    A Boshier
    Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, UK
    Pharmacoepidemiol Drug Saf 14:373-6. 2005
  5. ncbi request reprint A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil
    A Boshier
    Drug Safety Research Unit, Southampton, UK
    Int J Clin Pharmacol Ther 40:422-3. 2002
  6. ncbi request reprint Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction
    Karyn M Maclennan
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    BJU Int 98:125-31. 2006
  7. ncbi request reprint Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England
    Deborah Layton
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    Drug Saf 29:687-96. 2006
  8. ncbi request reprint An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease
    Lorna Hazell
    Drug Safety Research Unit, Southampton, UK
    BJU Int 99:387-93. 2007
  9. ncbi request reprint Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study
    Brian Chun-Fai-Chan
    The Motherisk Program, The Hospital for Sick Children, Toronto, Ontario, Canada
    Am J Obstet Gynecol 192:932-6. 2005

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England
    Deborah Layton
    Drug Safety Research Unit, Southampton, Hants, UK
    Drug Saf 29:897-909. 2006
    ....
  2. ncbi request reprint Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000
    Andrew Boshier
    Drug Safety Research Unit, Southampton, UK
    Eur J Clin Pharmacol 59:767-73. 2003
    ..In smoking cessation trials, it has been associated with minimal side effects. A range of suspected adverse drug reactions (ADRs) were reported via the spontaneous reporting system following its use in smoking cessation...
  3. ncbi request reprint Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999
    A Boshier
    Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton SO31 1AA, UK
    BJU Int 93:796-801. 2004
    ....
  4. ncbi request reprint The negative effect of red tape on research
    A Boshier
    Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, UK
    Pharmacoepidemiol Drug Saf 14:373-6. 2005
    ..To describe the kind of the difficulties encountered when seeking research governance approval for a nationwide public health and genetic study-the Drug-Induced Arrhythmia Risk Evaluation study-in England...
  5. ncbi request reprint A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil
    A Boshier
    Drug Safety Research Unit, Southampton, UK
    Int J Clin Pharmacol Ther 40:422-3. 2002
    ..Thus it remains important for clinicians to consider the range of risk factors for NAION; while equally, the processes of pharmacovigilance need to continue as for any recently launched drug preparation...
  6. ncbi request reprint Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction
    Karyn M Maclennan
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    BJU Int 98:125-31. 2006
    ..To examine the safety and use of apomorphine as prescribed in general medical practice in England as a treatment for erectile dysfunction (ED)...
  7. ncbi request reprint Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England
    Deborah Layton
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    Drug Saf 29:687-96. 2006
    ..Our objectives were to identify and describe cases of serious skin reactions reported during postmarketing studies of COX-2 selective inhibitors...
  8. ncbi request reprint An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease
    Lorna Hazell
    Drug Safety Research Unit, Southampton, UK
    BJU Int 99:387-93. 2007
    ....
  9. ncbi request reprint Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study
    Brian Chun-Fai-Chan
    The Motherisk Program, The Hospital for Sick Children, Toronto, Ontario, Canada
    Am J Obstet Gynecol 192:932-6. 2005
    ..The secondary objective was to examine the rates of live births, stillbirths, spontaneous and therapeutic abortions, mean birth weight, and gestational age at birth...